A. Krishnan - Concepedia

Author

A. Krishnan

Also Known As

A Krishnan, A Y Krishnan, A. Krishnan, A. Y. Krishnan, Aishwarya R Krishnan, Aishwarya laxmi Krishnan, Amrita Y. Krishnan, Ayana Krishnan, and K. Ranga Krishnan

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

City of Hope City Of Hope National Medical Center Dana-Farber Cancer Institute Moffitt Cancer Center Mayo Clinic in Arizona

About

A. Krishnan is an author at City of Hope specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	984
2	Immunology	7	7	324
3	Health Sciences	6	6	654
4	Blood Transplantation	6	6	317
5	Engineering	1	1	10

A. Krishnan

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study André Goy, Steven H. Bernstein, Brad S. Kahl, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaHealth SciencesUpdated Time-to-event AnalysesMedicine	2008	340
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome Henry C. Fung, Anthony S. Stein, Marilyn L. Slovak, Biology of Blood and Marrow Transplantation Transplantation OutcomeTransplantationMarrow TransplantationCytogenetic CharacteristicsMixed-phenotype Acute Leukemia	2003	118
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time Shaji Kumar, Angela Dispenzieri, Raphael Fraser, Leukemia Hematological MalignancyTransplantationMarrow TransplantationMedicineMalignant Blood Disorder	2017	85
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: Results of a prospective double-blind randomized trial Nelson J. Chao, DS Snyder, Maneesh Jain, Biology of Blood and Marrow Transplantation	2000	81
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study Shaji Kumar, Ian W. Flinn, Stephen J. Noga, Leukemia Hematological MalignancyMedicineHematologyMyeloid NeoplasiaPathology	2010	81
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis Anuj Mahindra, Parameswaran Hari, Raphael Fraser, Bone Marrow Transplantation UrologyTransplantationMarrow TransplantationKidney TransplantRenal Insufficiency	2017	65
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016 Kenneth C. Anderson, Melissa Alsina, Djordje Atanackovic, Journal of the National Comprehensive Cancer Network Hematological MalignancyMedicineCancer ManagementHematologyNccn Guidelines Insights	2016	60
Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation César O. Freytes, David H. Vesole, J Le-Rademacher, Bone Marrow Transplantation Transplant RejectionTransplantationHematologyTransplantation MedicineImmunology	2013	58
Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies Ari M. Vanderwalde, C.-L. Sun, Lester Laddaran, Leukemia TransplantationMarrow TransplantationCause-specific MortalityMedicineStem Cell Transplantation	2012	48
Multi-Center Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Promising Activity as Combination Therapy with Manageable Toxicity. Paul G. Richardson, Sagar Lonial, Andrzej Jakubowiak, Blood	2007	39

Page 1